ADHD Research Meeting in Philadelphia

This past weekend Dr Banov participated in an research meeting in
Philadelphia involving a new FDA-regulated clinical trial studying the prevalence
of certain genetic markers that may help researchers develop innovative drugs
for ADHD. Studying genotype/phenotype has already led to the development  of life saving drugs for Cystic Fibrosis, Pulmonary Hypertension and other serious medical disorders.  This is a very exciting area of clinical research and Dr. Banov will continue to monitor potential ADHD medications currently in the “Pipeline” which may ultimately receive FDA approval and become available to our patients.